S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NYSE:MMS

Maximus (MMS) Stock Forecast, Price & News

$64.12
+0.51 (+0.80%)
(As of 05/20/2022 07:00 PM ET)
Add
Compare
Today's Range
$63.01
$64.59
50-Day Range
$63.61
$77.62
52-Week Range
$63.01
$94.79
Volume
399,000 shs
Average Volume
404,240 shs
Market Capitalization
$3.94 billion
P/E Ratio
16.07
Dividend Yield
1.75%
Beta
0.7
30 days | 90 days | 365 days | Advanced Chart
Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for Maximus and its competitors with MarketBeat's FREE daily newsletter.

Maximus logo

About Maximus

Maximus, Inc. provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers various BPS solutions, such as program administration, appeals and assessments, and related consulting works for U.S. state and local government programs, including the Affordable Care Act, Medicaid, the Children's Health Insurance Program, Temporary Assistance to Needy Families, child support programs, Preadmission Screening and Resident Reviews, and Independent Developmental Disability assessments. This segment also provides program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; person-centered independent disability, long-term sick, and other health assessments; and specialized consulting services. The U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen support, and consumer education; independent medical reviews and worker's compensation benefit appeals; Medicare and Medicaid appeals; and federal marketplace eligibility appeals. This segment also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The Outside the U.S. segment offers BPS solutions for governments and commercial clients outside the United States, including health and disability assessments, program administration for employment services, and other job seeker-related services. The company was incorporated in 1975 and is headquartered in Reston, Virginia.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Data Processing & Outsourced Services
CUSIP
57793310
Employees
35,800
Year Founded
1975

Sales & Book Value

Annual Sales
$4.25 billion
Cash Flow
$6.81 per share
Book Value
$25.31 per share

Profitability

Net Income
$291.20 million
Pretax Margin
6.91%

Debt

Price-To-Earnings

Miscellaneous

Free Float
60,246,000
Market Cap
$3.94 billion
Optionable
Optionable

Company Calendar

Ex-Dividend for 2/28 Dividend
2/14/2022
Dividend Payable
2/28/2022
Last Earnings
5/04/2022
Ex-Dividend for 5/31 Dividend
5/12/2022
Today
5/22/2022
Dividend Payable
5/31/2022
Next Earnings (Estimated)
8/04/2022
Fiscal Year End
9/30/2022

Social Links


MarketRank

Overall MarketRank

2.91 out of 5 stars

Business Services Sector

24th out of 463 stocks

Business Services, Not Elsewhere Classified Industry

10th out of 141 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -













Maximus (NYSE:MMS) Frequently Asked Questions

Is Maximus a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Maximus in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Maximus stock.
View analyst ratings for Maximus
or view top-rated stocks.

Are investors shorting Maximus?

Maximus saw a decrease in short interest in the month of April. As of April 15th, there was short interest totaling 1,310,000 shares, a decrease of 23.8% from the March 31st total of 1,720,000 shares. Based on an average daily volume of 413,800 shares, the short-interest ratio is presently 3.2 days. Approximately 2.1% of the shares of the company are sold short.
View Maximus' Short Interest
.

When is Maximus' next earnings date?

Maximus is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Maximus
.

How were Maximus' earnings last quarter?

Maximus, Inc. (NYSE:MMS) announced its quarterly earnings data on Wednesday, May, 4th. The health services provider reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.98 by $0.09. The health services provider had revenue of $1.18 billion for the quarter, compared to analysts' expectations of $1.07 billion. Maximus had a net margin of 5.34% and a trailing twelve-month return on equity of 20.46%. The firm's revenue was up 22.7% compared to the same quarter last year. During the same period last year, the business earned $1.29 EPS.
View Maximus' earnings history
.

How often does Maximus pay dividends? What is the dividend yield for Maximus?

Maximus announced a quarterly dividend on Tuesday, April 12th. Stockholders of record on Friday, May 13th will be paid a dividend of $0.28 per share on Tuesday, May 31st. This represents a $1.12 dividend on an annualized basis and a yield of 1.75%. The ex-dividend date is Thursday, May 12th.
View Maximus' dividend history
.

Is Maximus a good dividend stock?

Maximus pays an annual dividend of $1.12 per share and currently has a dividend yield of 1.76%. The dividend payout ratio of Maximus is 28.07%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Maximus will have a dividend payout ratio of 21.33% next year. This indicates that Maximus will be able to sustain or increase its dividend.
View Maximus' dividend history.

What guidance has Maximus issued on next quarter's earnings?

Maximus updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of $4.07-$4.57 for the period, compared to the consensus earnings per share estimate of $4.12. The company issued revenue guidance of $4.50 billion-$4.70 billion, compared to the consensus revenue estimate of $4.52 billion.

What price target have analysts set for MMS?

1 brokers have issued 12 month price targets for Maximus' shares. Their forecasts range from $105.00 to $105.00. On average, they expect Maximus' share price to reach $105.00 in the next year. This suggests a possible upside of 63.8% from the stock's current price.
View analysts' price targets for Maximus
or view top-rated stocks among Wall Street analysts.

Who are Maximus' key executives?
Maximus' management team includes the following people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 55, Pay $3.24M) (LinkedIn Profile)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 61, Pay $1.04M) (LinkedIn Profile)
  • Ms. Michelle F. Link, Chief HR Officer (Age 47, Pay $915.97k) (LinkedIn Profile)
  • Mr. Thomas D. Romeo, Gen. Mang. of US Federal Services Segment
  • Mr. David Mutryn, CFO, Principal Financial Officer & Treasurer (Age 40)
  • Ms. Theresa D. Golinvaux, Principal Accounting Officer, Sr. VP & Corp. Controller (Age 47)
  • Mr. John Lambeth, Chief Information Officer
  • Mr. Jericho Seguin, Sr. VP of Corp. Devel.
  • Mr. David A. Casey, Sr. VP of Gov. Relations & Bus. Devel. (Age 62)
  • Ms. Deborah Homewood, Managing Director of Human Services - Australia
What is Bruce Caswell's approval rating as Maximus' CEO?

145 employees have rated Maximus CEO Bruce Caswell on Glassdoor.com. Bruce Caswell has an approval rating of 80% among Maximus' employees.

What other stocks do shareholders of Maximus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Maximus investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.com (JD).

What is Maximus' stock symbol?

Maximus trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Who are Maximus' major shareholders?

Maximus' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.42%), Vanguard Group Inc. (10.45%), Victory Capital Management Inc. (8.50%), Mackenzie Financial Corp (4.31%), State Street Corp (4.12%) and Fuller & Thaler Asset Management Inc. (1.81%). Company insiders that own Maximus stock include Bruce Caswell, David Francis, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, Richard A Montoni, Richard John Nadeau and Thomas D Romeo.
View institutional ownership trends for Maximus
.

Which institutional investors are selling Maximus stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., American Century Companies Inc., Bank of New York Mellon Corp, Arrowstreet Capital Limited Partnership, Neumeier Poma Investment Counsel LLC, Handelsbanken Fonder AB, Mondrian Investment Partners LTD, and JPMorgan Chase & Co.. Company insiders that have sold Maximus company stock in the last year include David Francis, Ilene R Baylinson, Michelle F Link, Peter Pond, Raymond B Ruddy, Richard A Montoni, and Richard John Nadeau.
View insider buying and selling activity for Maximus
or view top insider-selling stocks.

Which institutional investors are buying Maximus stock?

MMS stock was purchased by a variety of institutional investors in the last quarter, including Fuller & Thaler Asset Management Inc., Victory Capital Management Inc., William Blair Investment Management LLC, Vaughan Nelson Investment Management L.P., The Manufacturers Life Insurance Company , Federated Hermes Inc., Raymond James & Associates, and BlackRock Inc..
View insider buying and selling activity for Maximus
or or view top insider-buying stocks.

How do I buy shares of Maximus?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Maximus' stock price today?

One share of MMS stock can currently be purchased for approximately $64.12.

How much money does Maximus make?

Maximus has a market capitalization of $3.94 billion and generates $4.25 billion in revenue each year. The health services provider earns $291.20 million in net income (profit) each year or $3.99 on an earnings per share basis.

How many employees does Maximus have?

Maximus employs 35,800 workers across the globe.

When was Maximus founded?

Maximus was founded in 1975.

What is Maximus' official website?

The official website for Maximus is www.maximus.com.

How can I contact Maximus?

Maximus' mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at (703) 251-8500, via email at [email protected], or via fax at 703-251-8240.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.